Report Detail
Global Genital Herpes Treatment Market Insights, Forecast to 2025
- RnM2716772 |
- 14 June, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters. It is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Zovirax is the main brand available in the market for genital herpes. It can also treat chickenpox.
Among these drug types prevalent in the genital herpes treatment, Acyclovir segment dominated the global genital herpes treatment market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.
The global Genital Herpes Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Genital Herpes Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Genital Herpes Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Genital Herpes Treatment in these regions.
This research report categorizes the global Genital Herpes Treatment market by top players/brands, region, type and end user. This report also studies the global Genital Herpes Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva
Abbott
Sun
Mylan
Pfizer
GlaxoSmithKline
Dr. Reddy's
Novartis
Valeant
Market size by Product
Acyclovir
Valacyclovir
Famciclovir
Market size by End User
HSV-1
HSV-2
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Genital Herpes Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Genital Herpes Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Genital Herpes Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Genital Herpes Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Genital Herpes Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Genital Herpes Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Genital Herpes Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Genital Herpes Treatment Market Size Growth Rate by Product
- 1.4.2 Acyclovir
- 1.4.3 Valacyclovir
- 1.4.4 Famciclovir
- 1.5 Market by End User
- 1.5.1 Global Genital Herpes Treatment Market Size Growth Rate by End User
- 1.5.2 HSV-1
- 1.5.3 HSV-2
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Genital Herpes Treatment Market Size
- 2.1.1 Global Genital Herpes Treatment Revenue 2014-2025
- 2.1.2 Global Genital Herpes Treatment Sales 2014-2025
- 2.2 Genital Herpes Treatment Growth Rate by Regions
- 2.2.1 Global Genital Herpes Treatment Sales by Regions
- 2.2.2 Global Genital Herpes Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Genital Herpes Treatment Sales by Manufacturers
- 3.1.1 Genital Herpes Treatment Sales by Manufacturers
- 3.1.2 Genital Herpes Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Genital Herpes Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Genital Herpes Treatment Revenue by Manufacturers
- 3.2.1 Genital Herpes Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Genital Herpes Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Genital Herpes Treatment Price by Manufacturers
- 3.4 Genital Herpes Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Genital Herpes Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Genital Herpes Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Genital Herpes Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Genital Herpes Treatment Sales by Product
- 4.2 Global Genital Herpes Treatment Revenue by Product
- 4.3 Genital Herpes Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Genital Herpes Treatment Breakdown Data by End User
6 North America
- 6.1 North America Genital Herpes Treatment by Countries
- 6.1.1 North America Genital Herpes Treatment Sales by Countries
- 6.1.2 North America Genital Herpes Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Genital Herpes Treatment by Product
- 6.3 North America Genital Herpes Treatment by End User
7 Europe
- 7.1 Europe Genital Herpes Treatment by Countries
- 7.1.1 Europe Genital Herpes Treatment Sales by Countries
- 7.1.2 Europe Genital Herpes Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Genital Herpes Treatment by Product
- 7.3 Europe Genital Herpes Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Genital Herpes Treatment by Countries
- 8.1.1 Asia Pacific Genital Herpes Treatment Sales by Countries
- 8.1.2 Asia Pacific Genital Herpes Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Genital Herpes Treatment by Product
- 8.3 Asia Pacific Genital Herpes Treatment by End User
9 Central & South America
- 9.1 Central & South America Genital Herpes Treatment by Countries
- 9.1.1 Central & South America Genital Herpes Treatment Sales by Countries
- 9.1.2 Central & South America Genital Herpes Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Genital Herpes Treatment by Product
- 9.3 Central & South America Genital Herpes Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Genital Herpes Treatment by Countries
- 10.1.1 Middle East and Africa Genital Herpes Treatment Sales by Countries
- 10.1.2 Middle East and Africa Genital Herpes Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Genital Herpes Treatment by Product
- 10.3 Middle East and Africa Genital Herpes Treatment by End User
11 Company Profiles
- 11.1 Teva
- 11.1.1 Teva Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Teva Genital Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Teva Genital Herpes Treatment Products Offered
- 11.1.5 Teva Recent Development
- 11.2 Abbott
- 11.2.1 Abbott Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Abbott Genital Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Abbott Genital Herpes Treatment Products Offered
- 11.2.5 Abbott Recent Development
- 11.3 Sun
- 11.3.1 Sun Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sun Genital Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sun Genital Herpes Treatment Products Offered
- 11.3.5 Sun Recent Development
- 11.4 Mylan
- 11.4.1 Mylan Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Mylan Genital Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Mylan Genital Herpes Treatment Products Offered
- 11.4.5 Mylan Recent Development
- 11.5 Pfizer
- 11.5.1 Pfizer Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Pfizer Genital Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Pfizer Genital Herpes Treatment Products Offered
- 11.5.5 Pfizer Recent Development
- 11.6 GlaxoSmithKline
- 11.6.1 GlaxoSmithKline Company Details
- 11.6.2 Company Business Overview
- 11.6.3 GlaxoSmithKline Genital Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 GlaxoSmithKline Genital Herpes Treatment Products Offered
- 11.6.5 GlaxoSmithKline Recent Development
- 11.7 Dr. Reddy's
- 11.7.1 Dr. Reddy's Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Dr. Reddy's Genital Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Dr. Reddy's Genital Herpes Treatment Products Offered
- 11.7.5 Dr. Reddy's Recent Development
- 11.8 Novartis
- 11.8.1 Novartis Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Novartis Genital Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Novartis Genital Herpes Treatment Products Offered
- 11.8.5 Novartis Recent Development
- 11.9 Valeant
- 11.9.1 Valeant Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Valeant Genital Herpes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Valeant Genital Herpes Treatment Products Offered
- 11.9.5 Valeant Recent Development
12 Future Forecast
- 12.1 Genital Herpes Treatment Market Forecast by Regions
- 12.1.1 Global Genital Herpes Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Genital Herpes Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Genital Herpes Treatment Market Forecast by Product
- 12.2.1 Global Genital Herpes Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Genital Herpes Treatment Revenue Forecast by Product 2019-2025
- 12.3 Genital Herpes Treatment Market Forecast by End User
- 12.4 North America Genital Herpes Treatment Forecast
- 12.5 Europe Genital Herpes Treatment Forecast
- 12.6 Asia Pacific Genital Herpes Treatment Forecast
- 12.7 Central & South America Genital Herpes Treatment Forecast
- 12.8 Middle East and Africa Genital Herpes Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Genital Herpes Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Genital Herpes Treatment . Industry analysis & Market Report on Genital Herpes Treatment is a syndicated market report, published as Global Genital Herpes Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Genital Herpes Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
